Express Scripts (ESRX) weekly volatility elevated, into contract with Anthem (ANTM) unlikely to be renewed

Go back to Express Scripts (ESRX) weekly volatility elevated, into contract with Anthem (ANTM) unlikely to be renewed

Cowen is a Buyer of Express Scripts (ESRX) on Weakness

April 25, 2017 1:12 PM EDT

Cowen analyst Charles Rhyee is incrementally positive on Express Scripts (NASDAQ: ESRX) following the earnings call and would be buyers on today's weakness. The analyst reiterated an Outperform rating and price target of $83.

Rhyee sees limited downside risk as ANTM's contribution of... More

Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI

April 25, 2017 12:43 PM EDT

Evercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.

Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More

Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures

April 25, 2017 9:36 AM EDT

Morgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.

Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More